1 / 7

Vasculitis - Epidemiology: Future Trends and Best Regions to Focus Globally!

Download Sample Brochure @ http://tinyurl.com/zxm8g5o<br><br>A detailed qualitative analysis of the factors responsible for driving and restraining growth of the Vasculitis - Epidemiology Review and future opportunities are provided in the report.<br>

tharun
Download Presentation

Vasculitis - Epidemiology: Future Trends and Best Regions to Focus Globally!

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. EpiCast Report: Vasculitis - Epidemiology Forecast to 2024 Published on – 01 January, 2016 Single User Price: $3995 | No of Pages : 98 The report focuses on global major leading industry players with information such as company profiles, product picture and specifications, sales, market share and contact information. What’s more, the EpiCast Epidemiology Forecast to 2024 development trends and marketing channels are analyzed. Report: Vasculitis -

  2. Summary Vasculitis is a group of heterogeneous disorders affecting persons of both sexes and all ages. These disorders are characterized by inflammation and necrosis of the blood vessels including the veins, arteries, and capillaries. There are various forms of vasculitis, and their clinical expressions may differ greatly in terms of symptoms observed, severity and duration of the disease depending on disease site and type of blood vessels involved. Due to the lack of a uniformly accepted classification criteria for vasculitis, GlobalData epidemiologists obtained data for each vasculitis disorder from studies that categorized patients with vasculitis with the Chapel Hill Consensus Conference (CHCC) definitions.

  3. In the 7MM, GlobalData epidemiologists forecast that the diagnosed incident cases of vasculitis (includes AAV, LVV, BD, and KD) for ages 15 and older will increase from 82,019 diagnosed incident cases in 2014 to 95,428 diagnosed incident cases in 2024, at an Annual Growth Rate (AGR) of 1.63% during the forecast period. GlobalData epidemiologists forecast that the diagnosed prevalent cases of selected vasculitis disorders (includes AAV, TA, and BD) for ages 15 years and older will increase from 137,603 diagnosed prevalent cases in 2014 to 145,229 diagnosed prevalent cases in 2024, at an AGR of 0.55% during the forecast period. Click Here To Check Complete Report

  4. Scope - The Vasculitis EpiCast Report provides an overview of the risk factors and global trends of selected vasculitis disorders in the 7MM (US, France, Germany, Italy, Spain, UK, and Japan). The selected vasculitis disorders are anti-neutrophil cytoplasmic antibod-associated vasculitis (AAV) (microscopic polyangitis [MPA], granulomatosis with polyangitis [GPA], and eosinophilic granulomatosis with polyangitis [eGPA]), large vessel vasculitis (LVV) (giant cell arteritis [GCA] and Takayasu's arteritis [TA]), Behҫet’s disease (BD), and Kawasaki disease (KD). The report includes a 10-year epidemiological forecast for the diagnosed incident cases of AAV, LVV, BD, and KD, as well as the diagnosed prevalent cases of AAV, TA, and BD. Age and sex segmentations are also provided. Download Sample Brochure

  5. Reasons to buy The Vasculitis EpiCast report will allow you to - - Develop business strategies by understanding the trends shaping and driving the global vasculitis market. - Quantify patient populations in the global vasculitis market to improve product design, pricing, and launch plans. - Organize sales and marketing efforts by identifying the age groups and sex that present the best opportunities for vasculitis therapeutics in each of the markets covered. Make an Inquiry Before Buying

  6. Key questions answered in this report • What will the market size be in 2020 and what will the growth rate be? • What are the key market trends? • What is driving this market? • What are the challenges to market growth? • Who are the key vendors in this market space? • What are the market opportunities and threats faced by the key vendors? • What are the strengths and weaknesses of the key vendors? You can request one free hour of our analyst’s time when you purchase this market report. Details are provided within the report.

  7. EpiCast Report: Vasculitis - Epidemiology Forecast to 2024 A detailed qualitative analysis of the factors responsible for driving and restraining growth of the EpiCast Report: Vasculitis - Epidemiology Forecast to 2024 and future opportunities are provided in the report. Contact: 1-302-684-6088 sales@marketintelreports.com www.marketintelreports.com Click here to order a copy of EpiCast Report: Vasculitis - Epidemiology Forecast to 2024

More Related